SRRK Q4 2022 Earnings — Scholar Rock Holding Corporation Revenue & Financial Results | Market Cap Arena

SRRKScholar Rock Holding Corporation

$5B

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$3M

Operating Income

-$40M

Net Income

-$39M

EPS (Diluted)

$-0.74

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$29M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$358M

Total Liabilities

$98M

Stockholders' Equity

$260M

Cash & Equivalents

$103M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$4M	-100.0%
Gross Profit	-$3M	-$25M	+89.9%
Operating Income	-$40M	-$35M	-14.3%
Net Income	-$39M	-$36M	-9.3%